What the research examined
A publication describes observations in one person with severe, longstanding anorexia nervosa. It reports appetite-related, metabolic, and body-weight changes during the observation period. Its evidentiary value is that of a clinical case report rather than a controlled trial.
How to interpret the findings
Without randomization and a comparison group, causal attribution is limited. A single person's course cannot establish average effects, uncommon harms, or applicability to other populations.
Research literature
- One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient.
Journal of cachexia, sarcopenia and muscle · 2015 · PMID 26401470
Links open the indexed paper records. Summaries are based on those records and their available abstracts, not a systematic review or a full-text appraisal of every study.